Predictors of health-related quality of life among people with type II diabetes Mellitus in Ardabil, Northwest of Iran, 2014 by سید مرتضی, شمشیرگران et al.
pr imary care d iabetes 1 0 ( 2 0 1 6 ) 244–250
Contents lists available at ScienceDirect
Primary Care Diabetes
journa l homepage : h t tp : / /www.e l sev ie r . com/ loca te /pcd
Original research
Predictors of health-related quality of life among
people with type II diabetes Mellitus in Ardabil,
Northwest of Iran, 2014
Seyed Morteza Shamshirgarana, Jafar Ataeib,c,∗,
Manouchehr Iranparvar Alamdarid, Abdolrasool Safaeianb,
Nayyereh Aminisanib
a Department of Statistics and Epidemiology, School of Health Sciences and Injury Epidemiology Prevention Research
Center, Tabriz University of Medical Sciences, Tabriz, Iran
b Department of Statistics and Epidemiology, School of Health Sciences, Tabriz University of Medical Sciences, Tabriz,
Iran
c Khalkhal Health Center, School of Khalkhal Medical Sciences, Ardabil University of Medical Sciences, Ardabil, Iran
d Internal Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
a r t i c l e i n f o
Article history:
Received 29 June 2015
Received in revised form
21 October 2015
Accepted 7 November 2015
Available online 3 December 2015
Keywords:
Quality of life
T2DM
WHOQOL-BREF questionnaire
a b s t r a c t
Aims: The present study aims at investigating different dimensions of the Health-Related
Quality of Life (HRQOL) and its determinants among type II diabetesMellitus (T2DM) referred
to diabetes clinic in Ardabil.
Methods: The present study was conducted through a cross-sectional method in which 300
people with T2DM were selected using a convenience sampling method between January
andMay 2014. Datawere collected through 26-itemstructured andWHOQOL-BREF question-
naires. Data analysis was performed using descriptive and analytical statistical methods,
independent t-test, Mann Whitney test, ANOVA, Kruskal Wallis, Welch test, and multivari-
able linear regression model using SPSS (V.20).
Results: The mean age of the participants was 54.13±9.13, and about 72% of the patients
were women. The mean score of the total HRQOL was 53.07±17.09; the highest scoreIran of HRQOL was related to the environmental domain (57.10±10.52) and the lowest to the
dimension of social health (45.68±17.25). Based onmultivariable linear regression, total QOL
was inﬂuenced by gender, marital status, MHI, and comorbid renal disease. PH Dimension
was associated with MHI and neuropathy; PSH with education level, comorbid depression,
comorbid renal, and other disease; SR with marital, comorbid renal, and other disease; EH
with marital status, Monthly household income (MHI), and education level.
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Conclusion: According to the results of this study, Predictors of the HRQOL in T2DM are asso-
ciated with demographic and socioeconomic factors, comorbidities, and with less impact,
diabetes complications, respectively. Moreover, diabetic patients had moderate HRQOL, and
compared with men, scores of all domains were lower in women.
© 2015 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
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i. Introduction
ver the last decades, non-communicable diseases such as
iabetes have remarkably increased due to rapid urbanization,
nhealthy lifestyle, and aging [1]. World Health Organization
WHO) indicates that the “diabetes epidemic” will continue
n coming decades yielding enormous human and economic
osts around the world [2].
387 million people were reported diabetic worldwide pre-
icted to be risen to 592 million by 2035 [3]. In 2013, the
revalence of diabetes in Iran was reported 9.94% with more
han 4.5 million patients predicted to increase to 8.4 million
y 2035 [4]. Diabetes was the death cause of 5.1 million people
n 2013 [5], and according to the latest report of WHO in 2014,
t is the eighth cause of death in the world [6].
Due to the impossibility of complete treatment of chronic
iseases, assessing the quality of life (QOL) among patients
ith such diseases is an important outcome measure [7].
ccording to the deﬁnition proposed by WHO, QOL is deﬁned
s “individuals’ perception of their position in life in the con-
ext of the culture and value systems in which they live and in
elation to their goals, expectations, standards, and concerns”
8]. In most health-related literature, the term “health-related
uality of life” (HRQOL) is gradually accepted instead of QOL
hat is a multi-dimensional structure of subjective evaluation
f the good life including performance in relation to physical,
ental and social subjects [9].
As one of the common chronic diseases, diabetes causes
erious short- and long-term complications [10]. There is evi-
ence that diabetes and its complications of diabetes have a
egative impact on health related quality of life among people
ith diabetes [11].
In addition, healthy diet, adequate physical activity, med-
cation, and daily test of blood sugar and preserving it in a
ormal range can have many beneﬁts for diabetic patients
ffecting their HRQOL [12–14]. Some studies have shown the
nﬂuence of demographic factors, socioeconomic status and
linical factors such as comorbidities, depression, and dia-
etes control on QOL among people with diabetes [15–20].
QOL among people with diabetes has been assessed in
ome studies conducted in different regions of Iran using dif-
erent instrument and methodology. In general, the results
f these studies have shown that people with diabetes had
ower HRQOL score in comparison with non-diabetic people
21]. However, there is a limited number of studies examin-
ng the determinants of HRQOL among diabetic people in Iran
22–25].
Ardabil province is located in Northwest of Iran. People
iving in this area have Azari-Turkish background with differ-
nt sociocultural values inﬂuencing their lifestyle. Diabetes
s a research priority in Ardabil province [26], and previousstudies showed inadequate diabetes care and high prevalence
of complications in this population [27–29]. Therefore, the
assessment of HRQOL and its determinants plays an impor-
tant role in enhancing the quality of healthcare and the
management of the disease. The present study was designed
and conducted to investigate different dimensions of HRQOL
and its determinants among diabetic patients referring to
diabetes clinic (as a reference center for secondary level of
diabetes care) in Ardabil.
2. Methods
2.1. Subjects and study design
The present study was carried out using a cross-sectional
method. 300 individuals with T2DM having the study inclu-
sion criteria and referring to diabetes clinic of ImamKhomeini
Hospital during January and May 2014 were selected through
a convenience sampling method. The study inclusion criteria
include diagnosis of T2DM, age range 20 to 70 years of old, hav-
ing a caring record in the clinic, residing the urban regions of
the province, and not having special and debilitating diseases
(hemophilia and thalassemia). Exclusion criteria were unwill-
ingness to participate in the study and having other types of
diabetes.
The present study was approved by the Ethics Committee
of Tabriz University of Medical Sciences, and at the beginning
of the study, the informed consent was completed in written
form for all patients.
2.2. Measurements
Data collection was carried out by two trained interview-
ers using questionnaire. The questionnaire had two main
parts. In part one, general information including age, gender,
place of residence, marital status, Monthly household income
(MHI), health insurance, education level, treatment methods
(diet only, oral medications, insulin injection, insulin plus oral
medications), comorbidities (hypertension (HTN), depression,
renal disease, Cardiovascular disease (CVD) and stroke, other
diseases including blood lipid, thyroid dysfunction, arthritis
and cancer) disease duration, and complications (neuropathy,
retinopathy, nephropathy and Cardiovascular complications)
were collected.
In second part, the 26-item quality of life (WHOQOL-BREF)
questionnaire was employed to assess the HRQOL among
study participants. This questionnaire consists of 26 ques-
tions the ﬁrst two of which are designed to check the general
HRQOL and the level of the individual’s perception of the qual-
ity of his/her life, and the remaining 24 questions evaluate
the four domains of HRQOL including physical health (PH)
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Table 1 – Demographic data of 300 T2DM patients
referring to diabetes clinic of Ardabil in 2014.
Variable Variable N (%)
Age* 20–30 4 (1.3)
31–40 23 (7.7)
41–50 57 (19)
51–60 143 (47.7)
61–70 73 (24.3)
Gender Male 83 (27.7)
Female 217 (72.3)
Marital Status Single** 36 (12)
Married 264 (88)
Education level Illiterate 153 (51)
Elementary 81 (27)
Secondary 34 (11.3)
High School/Diploma 22 (7.3)
University Degree 10 (3.3)
Health Insurance Yes 281 (93.7)
No 17 (5.7)
Occupation Not mentioned 2 (6)
Ofﬁce worker 28 (9.3)
Laborer 19 (3.3)
Housekeeper 206 (68.7)
Retired/other*** 47 (18.7)
Monthly household
income****
<500 171 (57)
500–1000 71 (23.7)
>1000 10 (3.3)
Not mentioned 48 (16)
∗ Mean and standard deviation: 54.13±9.13.
∗∗ Never married, divorced, widow.
∗∗∗ Driver, self-employed, income without job, unemployed.
∗∗∗∗ Amounts are in 10000 Rials (1 US dollar equals to 32000 Islamic246 pr imary care d iab
(7 questions), psychological health (PSH) (6 questions), social
relationships (SR) (3 questions), and environmental health
(EH) (8 questions). A 5-point Likert scale was used to score
the questionnaire (not at all, a little, a moderate amount, very
much, and an extreme amount). Each question was assigned
1 to 5 points. The highest score in each dimension indicates
better HRQOL. During data analysis, questionnaires contain-
ing more than 20% unanswered items were crossed out. After
the raw score was calculated for each domain, the scores can
be analyzed and converted into scales of 0–100 or 4–20 accord-
ing to the guidelines ofWHO [30,31]. In thepresent study, 0–100
scale was employed. This questionnaire has been translated
andvalidated in 40 languages indifferent countries. Validation
of the Persian version was examined by Nejat et al. [32] and its
validity and reliability were also approved.
2.3. Statistical analysis
The data were analyzed using SPSS version 20. In addition
to descriptive statistical methods (mean±SD and frequency
(percent)), independent t-test, Mann–Whitney test, ANOVA
(followed with Tukey HSD post hoc analysis), Kruskal Wallis
(the post hoc analysis was pursued with Bonferroni corrected
Mann–Whitney test by Comparing pairwise subgroups), and
Welch test were applied in order to analyze the scores of life
quality according to demographic data, treatment methods,
and disease characteristics given the parametric and non-
parametric conditions of the data. Furthermore, multivariable
linear regression model was performed to estimate the rela-
tionships between the independent factors with quality of
life dimensions (PH, PSH, SR, EH and total HRQOL) Scores
(as dependent variables). The signiﬁcance level in the present
study was set at (p<0.05).
3. Results
The mean age of the participants was 54.13±9.13 about 72%
of whom were female, 88% married, 51% illiterate, 94% with
health insurance, and the Monthly income of 67.9% was
reported to be less than 500,000 Tomans1 (Table 1). Approx-
imately, 60% of the patients used oral medication. The most
frequent comorbidity was HTN (38.3%) 37.7% of which had
only one disease. Moreover, the mean duration of disease was
7.74±5.89 years. The most frequent diabetes complications
were neuropathy (23.7%) and retinopathy (20.7%), respectively
(Table 2).
Themean score of total HRQOLwas 53.07±17.09. Thehigh-
est and the lowest score of HRQOL were attributed to the
environment dimension (57.10±10.52) and social relations
domain (45.68±17.25), respectively. There was a signiﬁcant
difference between men and women in psychological domain
(p<0.05) (women with lower level than men) (Table 3). Scores
ofHRQOL among the patients only using diet as treatmentwas
higher in all domains (except for social relations). The lowest
score of HRQOL in all aspects was observed among patients
1 1USdollar equals to 3200 Tomans, 1 Toman equals to 10 Islamic
Republic of Iran’s Rials).Republic of Iran’s Rials).
with renal diseases. Moreover, the lowest HRQOL score in all
aspectswas observed amongpatientswith four comorbidities,
and only in social health, there was a signiﬁcant difference
among these groups domain (p<0.05). There was a signiﬁ-
cant difference between the subgroups of disease duration in
physical and mental dimensions (p<0.05) (Table 2).
As indicated bymultivariable linear regression results, total
HRQOL is inﬂuenced by gender (b:−5.787, 95% CI: −10.742
to −0.833), marital status (b: 8.058, 95% CI: 0.683 to 15.433),
MHI, and comorbid renal disease (b: 4.553, 95% CI: 0.597 to
8.508), (b:−9.829, 95% CI: −16.573 to −3.084), respectively. PH
dimensionwas associatedwithMHI andneuropathy; PSHwith
education, depression, renal and other disease; SR with mari-
tal status, renal and other disease; EHwithmarital status, MHI
and education level (Table 4).
4. Discussion
In the present study, the 26-item questionnaire of HRQOL
(WHOQOL-BREF) was utilized in order to investigate HRQOL
and its determinants among people with T2DM referring to
diabetes clinic (reference center) in Ardabil.
In this study, the mean score of total HRQOL was
53.07±17.09. Compared to some studies [33–35], people with
T2DMhad average scores of HRQOL in this study; In contrast, it
was higher for most patients [36–38] in comparison with some
studies that found unfavorable score of HRQOL.
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Table 2 – Different dimensions of QOL according to the clinical aspects of diabetes among 300 T2DM patients.
Variable Subgroups N (%) PH PSH SR EH Total QOL
Disease duration
(year)
5> 108 (36) 86.58 (11.89) 58.25 (12.49) 48.07 (15.93) 58.81 (10.82) 56.60 (16.66)
5–10 118 (39.3) 53.51 (11.66) 52.86 (11.76) 45.98 (18.19) 56.25 (10.41) 51.48 (16.03)
11–15 42 (14) 55.54 (11.21) 53.46 (15.53) 41.87 (19.59) 57.13 (10.78) 51.52 (21.50)
15< 30 (10) 52.12 (11.90) 54.44 (11.16) 42.56 (12.49) 54.35 (8.65) 50.00 (14.68)
p – 0.003# 0.013 ˇ *** 0.073*** 0.145 0.116***
Therapeutic
methods
Only diet 35 (11.7) 59.10 (10.85) 59.17 (14.21) 48.10 (13.90) 59.72 (7.93) 58.5 (18.13)
Oral medication 179 (59.7) 55.94 (12.02) 55.44 (12.76) 45.79 (17.12) 57.61 (10.73) 54.52 (17.07)
Insulin Injection 66 (22) 53.07 (13.08) 53.54 (13.17) 45.69 (18.72) 55.87 (10.95) 49.04 (17.10)
Oral
medication+ insulin
injection
13 (4.3) 50.32 (14.66) 53.57 (15.27) 50.38 (22.49) 55.26 (13.20) 52.72 (20.28)
p – 0.175*** 0.072*** 0.437*** 0.051 0.532***
Comorbidities* Blood pressure 115 (38.3) 54.30 (11.24) 53.57 (13.51) 43.02 (16.46) 55.58 (10.36) 51.10 (16.76)
Depression 19 (6.3) 53.02 (11.50) 49.20 (11.43) 47.92 (18.37) 60.38 (10.96) 50.00 (18.63)
Renal disease 18 (6) 50.41 (10.74) 49.05 (9.96) 38.43 (15.47) 53.75 (10.93) 44.59 (15.46)
Cardiovascular disease
and stroke
23 (7.7) 52.09 (10.08) 52.34 (13.25) 41.36 (14.87) 56.54 (10.98) 48.90 (17.72)
Other diseases** 34 (11.3) 53.26 (11.49) 51.88 (9.80) 41.18 (14.26) 55.22 (10.29) 51.08 (16.26)
Non 66 (22) 59.93 (13.42) 59.11 (12.31) 53.79 (19.13) 59.23 (9.18) 58.14 (16.63)
p – 0.261 0.994 0.939*** 0.967 0.598***
Number of
comorbidities
0 66 (22) 59.93 (13.42) 59.11 (12.31) 53.79 (19.13) 59.23 (9.18) 58.14 (16.63)
1 113 (37.7) 56.36 (12.94) 56.46 (13.55) 46.89 (17.41) 58.43 (11.40) 52.93 (17.51)
2 63 (21) 55.44 (12.43) 55.00 (12.48) 42.50 (18.58) 56.20 (10.58) 51.59 (19.12)
3 26 (8.7) 59.07 (10.75) 54.65 (14.06) 53.21 (16.17) 57.55 (10.34) 55.29 (16.27)
4 7 (2.3) 54.08 (4.34) 44.64 (3.96) 39.29 (22.42) 54.02 (5.62) 50.00 (10.21)
p – 0.254**** 0.173 0.021¥ *** 0.597 0.728***
Diabetes-related
complications*
Neuropathy 71 (23.7) 52.52 (13.41) 54.17 (14.16) 44.44 (22.45) 57.28 (12.43) 49.64 (19.15)
Retinopathy 62 (20.7) 51.82 (11.91) 53.14 (11.95) 42.64 (18.61) 55.02 (10.79) 49.80 (17.60)
Nephropathy 12 (4) 45.83 (10.64) 47.57 (8.42) 38.89 (10.86) 50.00 (7.13) 40.63 (16.96)
Cardiovascular
complications
22 (7.3) 52.11 (10.61) 52.48 (13.57) 37.50 (13.65) 56.72 (11.84) 48.21 (17.36)
Non 161 (53.7) 57.56 (10.87) 55.86 (12.03) 47.27 (15.25) 57.73 (9.47) 56.37 (15.14)
p – 0.083 0.173*** 0.236*** 0.638 0.710***
Abbreviations: QoL: quality of life; PH: physical health; PSH: psychological health; SR: social relationships; EH: environmental health.
ˇ Signiﬁcant differences according to the post hoc test related to disease duration <5 with 5–10 years.
¥ Signiﬁcant differences according to the post hoc test related to existence of 2 and 3 comorbidities.
∗ The patient can have more than one disease or more than one complication.
∗∗ Blood lipid, thyroid dysfunction, arthritis, cancer.
∗∗∗ p was reported based on Kruskal Wallis test and the rest based on ANOVA.
∗∗∗∗ p was reported based on Welch test.
# Signiﬁcant differences according to the post hoc test related to disease
Table 3 – The status of different domains of life quality accordin
QOL aspects No. of patients Total
Mean SD
PH 290 55.48 11.97
PSH 290 54.96 12.73
SR 293 45.68 17.25
EH 281 57.10 10.52
Total QOL 297 53.07 17.09
Abbreviations: QoL: quality of life; PH: physical health; PSH: psychological
∗ p was reported based on Independent t-test.
∗∗ p was reported based on Mann Whitney test.duration <5 with 5–10 and >15 years.
g to the gender of 300 people with T2DM.
Men Women p
Mean SD Mean SD
55.73 10.41 55.38 12.54 0.824*
57.70 10.80 53.93 13.26 0.016**
45.98 16.38 45.56 17.62 0.831**
58.18 9.46 56.69 10.88 0.292*
57.23 15.57 51.46 17.34 0.246**
health; SR: social relationships; EH: environmental health.
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Table 4 – Multivariate linear regression models of signiﬁcant factors predicting QoL domains in patients with T2DM.
QoL domains Variables B (SE) Beta p-Value 95% CI of B Adjusted R2
Lower Upper
PH Incomea 2.94 (1.474) 0.137 0.049 0.009 5.820 0.122
Nephropathyb −3.639 (1.797) −0.134 0.044 −7.182 −0.097
PSH Education levelc 2.291 (0.852) 0.192 0.008 0.612 3.971 0.158
Depressionb −8.250 (2.615) −0.201 0.002 −13.406 −3.094
Renal diseaseb −6.585 (2.444) −0.182 0.008 −11.402 −1.767
Other diseases*,b −3.756 (1.647) −0.145 0.024 −7.002 −0.510
SH Marital statusd 20.505 (2.922) 0.383 <0.001 14.751 26.260 0.238
Renal disease −7.701 (2.799) −0.149 0.006 −13.213 −2.188
Other diseases −6.290 (1.955) −0.176 0.001 −10.140 −2.440
EH Marital status 5.286 (2.212) 0.149 0.018 0.927 9.646 0.134
Income 3.276 (1.214) 0.179 0.007 0.884 5.668
Education level 1.897 (0.674) 0.196 0.005 0.568 3.226
Total QoL Gendere −5.787 (2.513) −0.148 0.022 −10.742 −0.833 0.148
Marital status 8.058 (3.741) 0.138 0.032 0.683 15.433
Income 4.553 (2.007) 0.144 0.024 0.597 8.508
Renal disease −9.829 (3.422) −0.194 0.004 −16.573 −3.084
Abbreviations: QoL: quality of life; PH: physical health; PSH: psychological health; SR: social relationships; EH: environmental health.
∗ Blood lipid, thyroid dysfunction, arthritis, cancer.
a 1. <500, 2. 500–1000 and 3. >100.
b 0. no, 1. yes.
c 1. Illiterate, 2. Elementary, 3. Secondary, 4. High School/Diploma, 5. University Degree.
d 1.Single (Never married, divorced, widow), 2. Married.
e 1. male, 2. female.
In the present study, most important independent predic-
tors ofHRQOLand its different dimensions amongpeoplewith
T2DMwere somedemographic and socioeconomic factors and
comorbidities. Basedonourﬁnding, scores of all domainswere
lower in women that were statistically signiﬁcant in psycho-
logical domain. This ﬁndings are in agreementwith the results
of many previous studies [24,33,36,37,39,40]. In contrast, in
another study; however, gender had no remarkable effect on
HRQOL [34]. Themain reason for this could be related to differ-
ent deﬁnitions of men and women for optimal living and the
consideration of different standards for QOL. Another reason
may be related to higher women’s concerns about the status
of their disease and inconsistency between responsibilities of
housekeeping and issues related to diabetesmanagement and
self-care. HRQOL has also been associated with MHI and edu-
cation level. These ﬁndings correspond with recent studies
conducted in Iran and other parts of the world [15,20,22,23].
Education level positively affected the QOL in the PSH and EH
domains. This association has been reported in different stud-
ies [15,20,22]. Marital status as a criterion of social support and
social and economic status was another important variable
positively predicting a patient’s HRQOL in SH and EH domains
(b: 20.505) and (b: 5.286), respectively. However, in our study,
similar to Bani–Issa’s study, marital status was not associated
with PH or PSH domains [35].
In regard with comorbidities and diabetes complications,
neuropathy as a complication of diabetes was signiﬁcantly
associated with PH (b: −3.639). This ﬁnding was conﬁrmed
by Solli et al. in Norway [10]. Overall, HRQOL score was
signiﬁcantly the lowest among patients with renal diseasescompared to those suffering from other diseases and compli-
cations. Other studies also conﬁrmed that people with T2DM
demonstrated poorer HRQOL in presence of complications
[41–43]. Comorbid depression was the most important nega-
tive predictor associated with worse HRQOL in PSH domain (b:
−8.250). This was in agreement with other studies reporting
this associations [18,44].
Other ﬁndings of this study indicated that the HRQOL total
or subtotal scores were different according to the number
of comorbidities, type of treatment, and duration of disease.
However, inmultivariate regressionmodel, this differencewas
not remained statistically signiﬁcant. In this study, the low-
est score was observed among people with four comorbidities
(39.22±22.42). Similarly, the results of the study conducted by
Patel showed a reverse and signiﬁcant relationship between
thenumber of comorbidities andHRQOL score [33]. The results
of this study also indicated that HRQOL was higher in all
domains among patientswith shorter duration of disease, and
it decreases almost in all dimensions with an increase in dis-
easeduration. In studies conductedbyHadipour,Aghamollaei,
and Patel, it was also concluded that there was a reverse and
signiﬁcant relationship between disease duration and scores
of HRQOL [24,25,33]. Probably, by increasing the duration of the
disease, the emergence of diabetes complications increases,
and treatments, diet, and restrictions related to disease con-
trol adversely affect HRQOL in diabetic patients.The highest and lowest scores of HRQOL were related to
patients with diet treatment and those with insulin injection
plus oral medication, respectively. In addition, the scores of
HRQOL were lower almost in all domains among the patients
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sing insulin injection than other groups. Similarly, other
tudies reported that HRQOL among patients using oral med-
cations was higher than those injecting insulin or taking oral
edications [42,44,45]. However, the results of other studies
ndicated that there was no signiﬁcant difference between
RQOL of patients using insulin injection and those taking
ral medication [37,39].
This study had some limitations. First, we used the
onvenience sampling method. Although this provides a
on-representative study population, incomplete personal
nformation in medical records, and address change because
f housing status, death, or migration were the main rea-
ons for using this method of sampling instead of a random
ampling. The authors recommend future studies use a more
igorous sampling method to improve ﬁnding generalizability.
econd, this study was conducted in a governmental sector
hat might be different with private sector reﬂecting the QOL
mong more afﬂuent people receiving different diabetes care
nd management.
. Conclusion
ccording to the results of this study, predictors of the HRQOL
n T2DM are associated with demographic and socioeco-
omic factors, comorbidities, and with less impact, diabetes
omplications, respectively. Moreover, people with T2DM had
oderate HRQOL, and compared with men, scores of all
omains were lower in women.
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